484 related articles for article (PubMed ID: 27847018)
1. More than half of presumptive multidrug-resistant cases referred to a tuberculosis referral laboratory in the Tigray region of Ethiopia are multidrug resistant.
Tesfay K; Tesfay S; Nigus E; Gebreyesus A; Gebreegziabiher D; Adane K
Int J Mycobacteriol; 2016 Sep; 5(3):324-327. PubMed ID: 27847018
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of tuberculosis, multidrug resistant tuberculosis and associated risk factors among smear negative presumptive pulmonary tuberculosis patients in Addis Ababa, Ethiopia.
Sinshaw W; Kebede A; Bitew A; Tesfaye E; Tadesse M; Mehamed Z; Yenew B; Amare M; Dagne B; Diriba G; Alemu A; Getahun M; Fikadu D; Desta K; Tola HH
BMC Infect Dis; 2019 Jul; 19(1):641. PubMed ID: 31324227
[TBL] [Abstract][Full Text] [Related]
3. Frequency of MTB and rifampicin resistance MTB using Xpert-MTB/RIF assay among adult presumptive tuberculosis patients in Tigray, Northern Ethiopia: A cross sectional study.
Wasihun AG; Dejene TA; Hailu GG
PLoS One; 2020; 15(11):e0240361. PubMed ID: 33147218
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and drug resistance profile of Mycobacterium tuberculosis isolated from pulmonary tuberculosis patients attending two public hospitals in East Gojjam zone, northwest Ethiopia.
Adane K; Ameni G; Bekele S; Abebe M; Aseffa A
BMC Public Health; 2015 Jun; 15():572. PubMed ID: 26092570
[TBL] [Abstract][Full Text] [Related]
5. Primary and secondary anti-tuberculosis drug resistance in Hitossa District of Arsi Zone, Oromia Regional State, Central Ethiopia.
Hamusse SD; Teshome D; Hussen MS; Demissie M; Lindtjørn B
BMC Public Health; 2016 Jul; 16():593. PubMed ID: 27430266
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of pulmonary multidrug-resistant tuberculosis patients in Tigray Region, Ethiopia: A cross-sectional study.
Welekidan LN; Skjerve E; Dejene TA; Gebremichael MW; Brynildsrud O; Agdestein A; Tessema GT; Tønjum T; Yimer SA
PLoS One; 2020; 15(8):e0236362. PubMed ID: 32797053
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Multi-Drug Resistant
Ali S; Khan MT; Khan AS; Mohammad N; Khan MM; Ahmad S; Noor S; Jabbar A; Daire C; Hassan F
Pol J Microbiol; 2020; 69(2):1-5. PubMed ID: 32249555
[TBL] [Abstract][Full Text] [Related]
8. Changing patterns and trends of multidrug-resistant tuberculosis at referral centre in Northern India: a 4-year experience.
Maurya AK; Singh AK; Kumar M; Umrao J; Kant S; Nag VL; Kushwaha RA; Dhole TN
Indian J Med Microbiol; 2013; 31(1):40-6. PubMed ID: 23508428
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of rifampicin resistant Mycobacterium tuberculosis among presumptive tuberculosis patients in selected governmental hospitals in Addis Ababa, Ethiopia.
Arega B; Menbere F; Getachew Y
BMC Infect Dis; 2019 Apr; 19(1):307. PubMed ID: 30947695
[TBL] [Abstract][Full Text] [Related]
10. Epidemiological profile of patients with rifampicin-resistant tuberculosis: an analysis of the Uganda National Tuberculosis Reference Laboratory Surveillance Data, 2014-2018.
Bahizi G; Majwala RK; Kisaka S; Nyombi A; Musisi K; Kwesiga B; Bulage L; Ario AR; Turyahabwe S
Antimicrob Resist Infect Control; 2021 May; 10(1):76. PubMed ID: 33964986
[TBL] [Abstract][Full Text] [Related]
11. Multidrug resistant tuberculosis: prevalence and risk factors in districts of metema and west armachiho, Northwest Ethiopia.
Mekonnen F; Tessema B; Moges F; Gelaw A; Eshetie S; Kumera G
BMC Infect Dis; 2015 Oct; 15():461. PubMed ID: 26503269
[TBL] [Abstract][Full Text] [Related]
12. Isolation of Mycobacterium tuberculosis from sputum of tribal, non-tribal pulmonary tuberculosis patients of Andaman & Nicobar islands by conventional culture method and assessment of first line anti-tuberculosis drug susceptibility patterns.
Mandal A; Parthasarathy G; Burma SP; Sugunan AP; Vijayachari P
Indian J Tuberc; 2015 Jan; 62(1):23-8. PubMed ID: 25857562
[TBL] [Abstract][Full Text] [Related]
13. Risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in a tertiary armed force referral and teaching hospital, Ethiopia.
Demile B; Zenebu A; Shewaye H; Xia S; Guadie A
BMC Infect Dis; 2018 May; 18(1):249. PubMed ID: 29855354
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and factors associated with multidrug/rifampicin resistant tuberculosis among suspected drug resistant tuberculosis patients in Botswana.
Tembo BP; Malangu NG
BMC Infect Dis; 2019 Sep; 19(1):779. PubMed ID: 31492099
[TBL] [Abstract][Full Text] [Related]
15. Additional Drug Resistance Patterns among Multidrug-Resistant Tuberculosis Patients in Korea: Implications for Regimen Design.
Mok JH; Kang BH; Lee T; Lee HK; Jang HJ; Cho YJ; Jeon D
J Korean Med Sci; 2017 Apr; 32(4):636-641. PubMed ID: 28244290
[TBL] [Abstract][Full Text] [Related]
16. First- and second-line anti-tuberculosis drug resistance in Northwest Ethiopia.
Tessema B; Beer J; Emmrich F; Sack U; Rodloff AC
Int J Tuberc Lung Dis; 2012 Jun; 16(6):805-11. PubMed ID: 22390880
[TBL] [Abstract][Full Text] [Related]
17. Multidrug-resistant and heteroresistant Mycobacterium tuberculosis and associated gene mutations in Ethiopia.
Mekonnen D; Admassu A; Mulu W; Amor A; Benito A; Gelaye W; Biadglegne F; Abera B
Int J Infect Dis; 2015 Oct; 39():34-8. PubMed ID: 26119857
[TBL] [Abstract][Full Text] [Related]
18. Multidrug-resistant Mycobacterium tuberculosis and associated risk factors in Oromia Region of Ethiopia.
Mulisa G; Workneh T; Hordofa N; Suaudi M; Abebe G; Jarso G
Int J Infect Dis; 2015 Oct; 39():57-61. PubMed ID: 26327121
[TBL] [Abstract][Full Text] [Related]
19. Resistance patterns among multidrug-resistant tuberculosis patients in greater metropolitan Mumbai: trends over time.
Dalal A; Pawaskar A; Das M; Desai R; Prabhudesai P; Chhajed P; Rajan S; Reddy D; Babu S; Jayalakshmi TK; Saranchuk P; Rodrigues C; Isaakidis P
PLoS One; 2015; 10(1):e0116798. PubMed ID: 25606853
[TBL] [Abstract][Full Text] [Related]
20. Multidrug resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis.
Eshetie S; Gizachew M; Dagnew M; Kumera G; Woldie H; Ambaw F; Tessema B; Moges F
BMC Infect Dis; 2017 Mar; 17(1):219. PubMed ID: 28320336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
